ARDS - Aridis Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,7578602,2692,862
Cost of Revenue23,00017,4388,1887,484
Gross Profit-20,243-16,578-5,919-4,622
Operating Expenses
Research Development----
Selling General and Administrative3,8743,1601,9653,284
Non Recurring----
Total Operating Expenses26,87420,59810,15310,768
Operating Income or Loss-24,117-19,738-7,884-7,906
Income from Continuing Operations
Total Other Income/Expenses Net2,012-4,918-538-296
Earnings Before Interest and Taxes-24,117-19,738-7,884-7,906
Interest Expense---366-296
Income Before Tax-22,105-24,656-8,422-8,202
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-22,105-24,656-8,422-8,202
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-22,105-24,656-8,422-8,202
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-23,462-27,449-8,887-8,202